معرفی
Jeffrey S. Berger, MD is an Associate Professor of Medicine and Surgery at NYU Grossman School of Medicine, where he also serves as Director of the Center for the Prevention of Cardiovascular Disease. He specializes in cardiology and preventive cardiology, treating adult patients with a focus on novel risk factors and platelet mechanisms in vascular disease.
Dr. Berger's research centers on platelet biology, thrombosis, and inflammatory mechanisms in cardiovascular disease. His lab investigates how platelet activity contributes to atherosclerosis, particularly in high-risk populations such as women with pregnancy complications, those with rheumatological conditions, and cancer survivors. He explores sex differences in cardiovascular pathophysiology and treatment response, and applies genomics and transcriptomics to develop personalized therapeutic strategies. His work spans basic science, translational research, and clinical trials.
His recent publications highlight the use of artificial intelligence in predicting coronary artery disease from imaging data, the role of platelet profiles in cardiometabolic risk, and perioperative cardiovascular risk assessment. These studies reflect a strong trend toward integrating molecular biomarkers with clinical outcomes to improve risk stratification and prevention.
Scientific Awards and Honors:
- Wolf Family Scholar (2016)
- Charles Klein Scholar (2015)
- NYU Research Incentive Award (2014-2015)
- Leon H. Charney Lecture Award (2014)
- Irma T. Hirschl/Monique Weill-Caulier Trusts Research Award (2013)
- Doris Duke Charitable Foundation Research Award (2011)
- American Heart Association Fellow to Faculty Award (2007)
Dr. Berger has received over $15 million in research funding, including from the National Institutes of Health. He mentors a multidisciplinary team of faculty, postdoctoral fellows, and research staff in the Berger Lab. His lab conducts NIH-funded studies on platelet activity in peripheral vascular disease, HIV, lupus, and rheumatoid arthritis, aiming to develop diagnostic tools and therapeutic targets based on platelet phenotype.
He leads the Berger Lab, which focuses on platelet biology, thrombosis, and inflammation in cardiovascular disease. The lab uses advanced techniques including platelet aggregometry, flow cytometry, and transcriptomics, and collaborates across disciplines to study platelets as effector cells in inflammatory diseases.
حوزههای پژوهشی
